Like My Pain Sensei

closed 5/14/2020 via PR Newswire

The DNA Company, acquired My Pain Sensei

synopsis: Canada-based The DNA Company has acquired AI-based digital therapeutics app My Pain Sensei (MPS), forming My Next Health. The DNA Company specializes in understanding how genes and genetic pathways influence health and wellness, and the acquisition of MPS gives My Next Health an AI-based platform to develop multiple health applications.
buyer: The DNA Company
The DNA Company is a Canadian functional genomics company that provides evidence-based therapies based on genomic insights that identify how genes and genetic pathways influence health and wellness. "
target: My Pain Sensei
My Pain Sensei (MPS) is an AI-based digital therapeutics app that helps users understand, manage, and communicate their chronic pain. MPS helps identify users' potential conditions with its Quick Assessment feature and creates a detailed and multi-dimensional Pain Report for care providers.
price ($mm)
$30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2020 via BNC Analysis

Tmm Software, acquired Hospiteasy

synopsis: TMM Software, a French developer of e-health software solutions, has acquired Hospiteasy, a French mobile app that connects patients to their doctors and hospitals. Hospiteasy simplifies hospital admissions by enabling patients to fill out and send in their admission forms from their phones before they arrive.
buyer: Tmm Software
France-based Tmm Software develops e-health software solutions for healthcare institutions, healthcare professionals and patients. TMM Software markets three software solutions, MultiMed, apTeleCare, and apFamilyLink, available to healthcare professionals and patients. "
target: Hospiteasy
Hospiteasy is a French mobile app that connects patients to their doctors and hospitals. Hospiteasy simplifies hospital admissions by enabling patients to fill out and send in their admission forms from their phones before they arrive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via GlobeNewswire

CareDx, Inc, acquired Transplant Hero LLC

synopsis: CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, has acquired Transplant Hero LLC, a New York-based provider of a mobile application supporting the needs of transplant patients.
buyer: CareDx, Inc (CDNA:$275.82)
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions along the pre- and post-transplant patient journey. "
target: Transplant Hero LLC
Transplant Hero is the developer of a mobile application that supports the needs of transplant patients. Transplant Hero is an interactive, educational, and simple to use tool that offers users positive reinforcement for medication adherence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/23/2022 via Company Press Release

WellSky, will acquire Tapcloud LLC

synopsis: WellSky, a global health and community care technology company, will acquire TapCloud, a virtual patient engagement technology company that helps patients, caregivers, and clinicians to communicate crucial information in real-time. Their AI-driven platform provides patient-generated insights that enable providers to deploy care interventions.
buyer parent: TPG Capital
buyer: WellSky
WellSky is a technology company advancing human wellness. Its software and professional services address the continuum of health and social care by helping businesses, organizations, and communities solve challenges, improve collaboration, and achieve better outcomes through predictive insights. "
target: Tapcloud LLC
TapCloud is a virtual patient engagement technology company. TapCloud helps patients, caregivers, and clinicians to communicate crucial information in real-time. Their AI-driven platform provides patient-generated insights that enable providers to deploy care interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/15/2022 via BNC Analysis

Docprime Technologies, acquired Visit

synopsis: Docprime Technologies, India’s 1st digital health locker, has acquired a 98.4% stake in Visit Internet Services Pvt Ltd, an AI-powered telemedicine platform in India. Visit provides a mobile platform that allows patients to connect with top healthcare specialists over video/voice call within 30 minutes.
buyer parent: PB Fintech Limited
buyer: Docprime Technologies
Docprime is India’s 1st digital health locker. Docprime aims to redefine how Indians seek healthcare services. Their mobile and online platform allows patients to securely store and manage all of their personal health records online. Their solution makes it easier to share records with doctors. "
target: Visit
Visit is an AI-powered telemedicine platform in India. Visit provides a mobile platform that allows patients to connect with top healthcare specialists over video/voice call within 30 minutes. The app also enables users to easily check their symptoms, track fitness activity, and log their meals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/18/2022 via BNC Analysis

iZafe, will acquire Pilloxa

synopsis: iZafe Group AB (publ), a Swedish Life-Science company, will acquire Pilloxa AB, a Swedish company that aims to make people healthier through technology. Pilloxa develops branded apps for patients to support them in adherence to their treatment and to connect patients, healthcare providers and the pharmaceutical industry.
buyer: iZafe (OM:IZAFE B:$0.04)
iZafe is a Swedish Life-Science company. iZafe develops medical and digital security solutions to create safer drug handling at home. The company's digital medication dispenser, Dosell, reduces the risk of incorrect medication, increases security for family, and relieves public care personnel. "
target: Pilloxa
Pilloxa is a Swedish company that aims to make people healthier through technology. Pilloxa develops branded apps for patients to support them in adherence to their treatment and to connect patients, healthcare providers and the pharmaceutical industry.
price ($mm)
$2.94
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/27/2020 via BusinessWire

Nemaura Medical, Inc., will acquire Healthimation, LLC

synopsis: Nemaura Medical, Inc., a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT, is to acquire Healthimation, LLC, a company that offers an application-based diabetes prevention program.
buyer: Nemaura Medical, Inc. (NMRD:$0.00)
Nemaura Medical is a UK based medical technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. "
target: Healthimation, LLC
Healthimation is commercializing an application-based diabetes prevention program that has been developed over a period of over 12 years and is supported with clinical data that has been widely published in scientific journal articles.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2020 via BusinessWire

Tandem Diabetes Care, Inc., acquired Sugarmate, Inc.

synopsis: Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, has acquired Sugarmate, a popular mobile app for people with diabetes who use insulin. The Sugarmate app is designed to help people with diabetes visualize diabetes therapy data in innovative ways.
buyer: Tandem Diabetes Care, Inc. (TNDM:$394.24)
Tandem Diabetes Care is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. "
target: Sugarmate, Inc.
Sugarmate is a mobile application designed to help people with diabetes visualize diabetes therapy data in innovative ways. It allows users to log glucose data and health and nutrition information, and can provide notifications and alerts to users, their family, and their caregivers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2020 via BNC Analysis

Huma, acquired BioBeats

synopsis: UK-based Huma has acquired BioBeats, a digital health company. Headquartered in London, BioBeats uses AI and Machine Learning in conjunction with biometrics to provide personalized stress and productivity tools. BioBeats' app BioBase pairs with biosensors and wearable devices to gather biometric data, such as heart rate variability.
buyer: Huma
UK-based Huma partners with scientists, technologists, and healthcare professionals to understand, treat, and ultimately prevent ill health. Huma gives knowledge and power to those with medical conditions while saving clinicians time, energy, and valuable resources. "
target: BioBeats
UK-based BioBeats is a digital health company and developer of BioBase, a mental health and wellbeing support app. BioBase pairs with biosensors and wearable devices to gather biometric data that is used in conjunction with AI and machine learning to develop personalized stress management tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BNC Analysis

Tmm Software, acquired Mental Apps SAS

synopsis: Tmm Software, a French group that develops e-health software solutions for healthcare institutions, healthcare professionals, and patients, has acquired the Lyon-based Mental Apps, a digital health company dedicated to mental disorders. Mental Apps helps psychiatrists and general practitioners follow their patients between consultations.
buyer: Tmm Software
France-based Tmm Software develops e-health software solutions for healthcare institutions, healthcare professionals and patients. TMM Software markets three software solutions, MultiMed, apTeleCare, and apFamilyLink, available to healthcare professionals and patients. "
target: Mental Apps SAS
Created in 2016 by Dr. Laurent Zukervar, Mental Apps is a French digital health company dedicated to mental disorders. Its mobile solutions help psychiatrists and general practitioners better follow their patients between consultations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2022 via PR Newswire

Mymee, acquired Breakthrough Health

synopsis: Mymee, a leading provider of specialized care and support for people with autoimmune diseases, has acquired Breakthrough Health, a digital health startup based in Berlin. Breakthrough Health's Emilyn app enables people living with multiple sclerosis to track their symptoms, set medication reminders, and securely share their health records.
buyer: Mymee
Mymee is a leader in precision health and nutrition. Mymee empowers people with autoimmune diseases to make sense of and manage their symptoms. They provide patients with virtual, one-on-one sessions with a certified health coaches to help them find what triggers their symptoms. "
target: Breakthrough Health
Breakthrough Health is a digital health startup based in Berlin. Breakthrough Health's Emilyn app empowers people living with multiple sclerosis to understand their condition better. The app allows users to track their symptoms, set medication reminders, and securely share their health records.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via PR Newswire

Progentec Diagnostics, Inc., acquired LupusCorner

synopsis: Progentec Diagnostics, Inc. (Progentec), a leader in the development of technological innovations in the field of diagnostics, has acquired LupusCorner, a health management platform for people living with lupus. LupusCorner provides articles and information about lupus to help individuals better understand their health and medications.
buyer: Progentec Diagnostics, Inc.
Progentec Diagnostics is a leader in the development of technological innovations in the field of diagnostics. The company's mission is to develop patented non-invasive and easy to use diagnostic solutions that target difficult to diagnose diseases. "
target: LupusCorner
LupusCorner is a health management platform for people living with lupus. The platform provides articles and information about lupus to help individuals better understand their health and medications. Their mobile app provides people with the tools they need to manage their lupus.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/14/2022 via GlobeNewswire

Bardavon Health Innovations, acquired PeerWell, Inc.

synopsis: Bardavon Health Innovations, an industry-leading provider of musculoskeletal health solutions in the physical therapy space focused on getting the workers of America back to work and life, has acquired PeerWell, Inc., a consumer-focused musculoskeletal (MSK) health application to create a truly hybrid treatment solution for workers across America.
buyer: Bardavon Health Innovations
Bardavon is an industry-leading provider of musculoskeletal health solutions in the physical therapy space focused on getting the workers of America back to work and life. "
target: PeerWell, Inc.
PeerWell, Inc. is a consumer-focused musculoskeletal (MSK) health application to create a truly hybrid treatment solution for workers across America.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2017 via BusinessWire

Digital Health Corp, acquired Constant Therapy

synopsis: Digital Health Corp, a diversified healthcare company focused on developing affordable therapy solutions to help patients get better in the comfort and convenience of their own homes, announced the acquisition of Constant Therapy, a developer of mobile solutions to treat patients with traumatic brain injury, stroke, aphasia, and learning disorders.
buyer: Digital Health Corp
Digital Health Corp is a diversified healthcare company that harnesses the power of the latest technology to create personalized and affordable home-based therapy solutions that accelerate and improve patient recovery from surgical intervention, injury, or illness. "
target: Constant Therapy
Constant Therapy is a developer of mobile solutions to treat patients with traumatic brain injury (TBI), stroke, aphasia, and learning disorders. Their comprehensive set of tools are in use at nationally recognized rehabilitation institutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/30/2022 via BusinessWire

Linus Health, acquired Kinesis Health Technologies

synopsis: Linus Health, a Boston-based digital health company focused on brain health, announced the completion of its acquisition of Kinesis Health Technologies, a Dublin-based leader in physical function assessment for older adults.
buyer: Linus Health
Linus Health is a digital health company focused on transforming brain health for people across the world. By advancing how we detect, diagnose, and address cognitive and brain disorders, their goal is to enable a future where people can live longer and healthier lives with better brain health. "
target: Kinesis Health Technologies
Kinesis Health Technologies Limited is an award-winning digital health company based in Dublin, Ireland. Kinesis solutions utilize sensors, artificial intelligence, and machine learning to produce comprehensive and accurate assessments of gait, mobility, balance, and falls risk in older adults.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2022 via BNC Analysis

DaVita Inc., acquired MedSleuth, Inc.

synopsis: Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates. MedSleuth offers software solutions to help improve the transplant process for patients, with tools to evaluate candidates.
buyer: DaVita Inc. (NYSE:DVA:$11,580.15)
DaVita Inc., a Fortune 500 company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. "
target: MedSleuth, Inc.
MedSleuth, a transplant software company, offers software solutions to help improve the transplant process for patients, with tools to evaluate candidates, make sure they stay active on the waitlist and connect them with providers and care teams.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/10/2014 via PR Newswire

Alphaeon Corporation, acquired TouchMD

synopsis: ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired TouchMD. TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates.
buyer parent: Strathspey Crown
buyer: Alphaeon Corporation
Alphaeon Corporation is a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. "
target: TouchMD
TouchMD is an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation, which enhances the patient experience and increases conversion rates. They offer product lines in Plastics, OBGYN, Dermatology, and Orthopedics.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/28/2014 via BusinessWire

Accolade, Inc., acquired konciergeMD

synopsis: Accolade, an innovative consumer engagement company, has acquired konciergeMD, a cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes. The acquisition will enahnce Accolade's leading consumer healthcare engagement service.
buyer: Accolade, Inc. (:$155.57)
Accolade uses their Accolade Health Assistants- a single point of contact for any health benefit or healthcare need, to improve people's healthcare experience while lowering costs for large employers, payers and Accountable Care Organizations. "
target: konciergeMD
konciergeMD is a first-of-its-kind, cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/16/2020 via BNC Analysis

Fuming Yang, acquired Kelinda

synopsis: Fuming Yang, a Chinese entrepreneur, has acquired a 99% stake in Kelinda, a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and appointments.
buyer: Fuming Yang
Fuming Yang is a Chinese entrepreneur. Fuming Yang is the founder of Liuzhou Bangfu Technology Co., Ltd., a company focusing on internet technology development, maintenance and services. Mr. Yang was also involved in various media projects, such as Star Avenue on CCTV. "
target: Kelinda
Kelinda is a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and doctor appointments.
price ($mm)
$0.33*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2020 via PR Newswire

The DNA Company, acquired My Pain Sensei

synopsis: Canada-based The DNA Company has acquired AI-based digital therapeutics app My Pain Sensei (MPS), forming My Next Health. The DNA Company specializes in understanding how genes and genetic pathways influence health and wellness, and the acquisition of MPS gives My Next Health an AI-based platform to develop multiple health applications.
buyer: The DNA Company
The DNA Company is a Canadian functional genomics company that provides evidence-based therapies based on genomic insights that identify how genes and genetic pathways influence health and wellness. "
target: My Pain Sensei
My Pain Sensei (MPS) is an AI-based digital therapeutics app that helps users understand, manage, and communicate their chronic pain. MPS helps identify users' potential conditions with its Quick Assessment feature and creates a detailed and multi-dimensional Pain Report for care providers.
price ($mm)
$30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2020 via PR Newswire

The DNA Company, acquired My Pain Sensei

synopsis: Canada-based The DNA Company has acquired AI-based digital therapeutics app My Pain Sensei (MPS), forming My Next Health. The DNA Company specializes in understanding how genes and genetic pathways influence health and wellness, and the acquisition of MPS gives My Next Health an AI-based platform to develop multiple health applications.
buyer: The DNA Company
The DNA Company is a Canadian functional genomics company that provides evidence-based therapies based on genomic insights that identify how genes and genetic pathways influence health and wellness. "
target: My Pain Sensei
My Pain Sensei (MPS) is an AI-based digital therapeutics app that helps users understand, manage, and communicate their chronic pain. MPS helps identify users' potential conditions with its Quick Assessment feature and creates a detailed and multi-dimensional Pain Report for care providers.
price ($mm)
$30
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2021 via Company Press Release

InVitae, acquired Genosity

synopsis: Invitae, a leading medical genetics company, announced it has acquired Genosity Inc., a genomics company offering innovative software and laboratory solutions to enable development and deployment of complex sequencing based tests.
buyer: InVitae (NVTA:$460.45)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: Genosity
Genosity is a life science biotechnology company that employs its expertise, novel software solutions and laboratory services for both somatic and germline applications to enable its strategic partners to fully realize the value of precision medicine for both the research and clinical markets.
price ($mm)[EV]
$196 [$195]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2009 via BusinessWire

Beckman Coulter, Inc., acquired Cogenics

synopsis: Clinical Data, Inc. announced that it has completed the sale of Cogenics, the Company’s genomics services division, to Beckman Coulter, Inc. As previously announced, the sale achieves Clinical Data’s goal to monetize non-core assets and focus resources on advancing its two late-stage targeted therapeutic programs.
buyer: Beckman Coulter, Inc. (BEC:$3,260.60)
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. "
target parent: Clinical Data, Inc.
target: Cogenics
Cogenics’ genomics solutions span current and next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments.
price ($mm)
$14
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like My Pain Sensei


read more

My Pain Sensei

Hospiteasy

Transplant Hero LLC

Tapcloud LLC

Visit

Pilloxa

Healthimation, LLC

Sugarmate, Inc.

BioBeats

Mental Apps SAS

Breakthrough Health

LupusCorner

PeerWell, Inc.

Constant Therapy

Kinesis Health Technologies

MedSleuth, Inc.

TouchMD

konciergeMD

Kelinda

Omhu A/S

read more

My Pain Sensei

read more

My Pain Sensei

read more

Genosity

Cogenics

Geography
Matching Companies
Ticker: HLSE:HEALTH
 
 
 
 
 
 
 
 
Nightingale Health Plc
Nightingale Health Plc
Nightingale Health is a Finnish health technology company. Nightingale's mission is to bring disease prevention and a healthier life within everyone's reach. They offer a mobile blood testing platform that allows users to easily understand their current health and improve their wellbeing.
year
2020
rev ($mm)
$2.65
EBITDA ($mm)
($4.36)
EBIT ($mm)
($4.51)
Net Income ($mm)
Employees
77
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: CNSX:NARA
 
 
 
 
 
 
 
 
PanGenomic Health Inc.
PanGenomic Health Inc.
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness.
year
2021
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.26)
Net Income ($mm)
Employees
5
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OM:COALA
 
 
 
 
 
 
 
 
Coala Life
Coala Life
Coala Life is a Swedish medical device company focused on cloud-based cardiac and pulmonary diagnostics. Coala Life's Coala Heart Monitor is a cloud-based product and app that enables long-term remote monitoring, analysis and algorithm-based diagnostics of the heart.
year
2021
rev ($mm)
$0.41
EBITDA ($mm)
($5.86)
EBIT ($mm)
($5.95)
Net Income ($mm)
Employees
29
  • drill down
  • watch
Ticker: OTCPK:ADHC
 
 
 
 
 
 
 
 
American Diversified Holdings Corporation
American Diversified Holdings Corporation
American Diversified Holdings Corporation (ADHC) is a publicly traded holding company providing executive management, corporate governance, administrative support, financial advisory services, investment capital sourcing, and regulatory affairs to both private and public companies.
year
2012
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.45)
Net Income ($mm)
Employees
3
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
39
  • drill down
  • watch
Ticker: AIM:INHC
 
 
 
 
 
 
 
 
Induction Healthcare Group PLC
Induction Healthcare Group PLC
Induction Healthcare is a healthcare technology company in the UK. Induction Healthcare offers a secure communications toolkit that allows healthcare professionals to connect with the people they need, collaborate in teams and communicate securely in complex clinical environments.
year
2019
rev ($mm)
EBITDA ($mm)
($3.63)
EBIT ($mm)
($3.65)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CDNA
 
 
 
 
 
 
 
 
CareDx, Inc
CareDx, Inc
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
year
2021
rev ($mm)
$275.82
EBITDA ($mm)
($9.14)
EBIT ($mm)
($17.39)
Net Income ($mm)
Employees
466
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker: NVTA
 
 
 
 
 
 
 
 
InVitae
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today.
year
2021
rev ($mm)
$460.45
EBITDA ($mm)
($694.07)
EBIT ($mm)
($774.54)
Net Income ($mm)
Employees
3000
  • drill down
  • watch